Neoplasms

All Conditions

Symptoms and General Pathology

Digestive System Diseases

Carcinoma

Neoplasm Metastasis

Carcinoma, Hepatocellular

Recurrence

Neoplasms, Glandular and Epithelial

Neoplasms by Histologic Type

Adenocarcinoma

Liver Neoplasms

Gastrointestinal Neoplasms

Digestive System Neoplasms

Gastrointestinal Diseases

Liver Diseases

Disease Attributes

Antineoplastic Agents

All Drugs and Chemicals

Hematinics

Anti-Infective Agents

Gemcitabine

Doxorubicin

Liposomal doxorubicin

Fluorouracil

Cisplatin

Oxaliplatin

Liver Extracts

Antimetabolites

Anti-Bacterial Agents

Antibiotics, Antitubercular

Enzyme Inhibitors

Gemcitabine 1000mg/m2 (days l, 8) and oxaliplatin 130mg/m2 (day l) delivered as an intravenous infusion, given every 28days and repeat six times.

gemcitabine and oxaliplatin

Doxorubicin 20mg/m2 (days 1, 3), 5-Fu 300mg/m2 (days 1-5) and cisplatin 20mg/m2 (days 1-3) delivered as an intravenous infusion, given every 28days and repeat six times.

doxorubicin, 5-Fu and cisplatin

Jun-Yi Wu, MM

Zhi-Hai Peng, MD

Jun-Wei Fan, MD

The study is designed to investigate the effect of postoperative adjuvant chemotherapy in prevention of tumor recurrence and metastasis for hepatocellular carcinoma after liver transplantation.

Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation

Examination of tumor recurrence include serum levels of alpha-fetoprotein(AFP), chest radiography, abdominal ultrasonography, chest or abdominal computed tomography (CT), magnetic resonance imaging (MRI) and bone scintigraphy

Postoperative survival include rates of disease-free survival (DFS), overall survival(OS), tumor recurrence and death.

Shanghai Changzheng Hospital

Shanghai Jiao Tong University School of Medicine

Shanghai First People's Hosptial

Neoplastic Processes

Central Nervous System Depressants

Anesthetics

In this group，the patient is received radiofrequency ablation under general anesthesia.

In this group，the patient is received radiofrequency ablation under local anesthesia.

the patient received generalanesthesia and local anesthesia randomly

general anesthesia and local anesthesia

diansan su, Ph.D

The purpose of this study was to investigate whether general anesthesia will affect the postoperative recurrence and metastasis of malignant tumor.

the Influence of General Anesthesia on Tumor Metastasis and Recurrence

Follow-up of patients with tumor recurrence and metastasis after Radiofrequency ablation to 3 years

RenJi Hospital

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation	NCT01125020	Liver Transplan... Hepatocellular ... Tumor Recurrenc... Survival Adjuvant Chemot...	gemcitabine and... doxorubicin, 5-...	18 Years -	Shanghai Jiao Tong University School of Medicine
the Influence of General Anesthesia on Tumor Metastasis and Recurrence	NCT02474511	Tumor Recurrenc...	general anesthe...	18 Years - 65 Years	RenJi Hospital
the Influence of General Anesthesia on Tumor Metastasis and Recurrence	NCT02474511	Tumor Recurrenc...	general anesthe...	18 Years - 65 Years	RenJi Hospital

Spots Global Cancer Trial Database for tumor recurrence and metastasis